The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary ...

Single-port robotic surgery sparked interest and debate at the American Urological Association annual meeting (AUA 2025).

A randomized controlled trial investigated use of sodium glucose cotransporter 2 inhibitors (SGLT2i) on top of standard care immunosuppression in lupus nephritis.

Researchers have found that renal denervation in patients with hypertension is associated in significant improvements in systolic blood pressure.

Jacek Skarbinski, M.D., from Oakland Medical Center in California, and colleagues assessed COVID-19 vaccine effectiveness (VE) and the number needed-to-vaccinate (NNV) among people with cancer. The ...

A meta-analysis of studies compared gold standard radical cystectomy and an alternative, trimodality therapy, for muscle-invasive bladder cancer.

(HealthDay News) — Patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, according to a study published online July 28 in ...

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or overweight.

The FDA has granted Fast Track designation to SAP-001 for the treatment of hyperuricemia in adult patients with gout who are refractory to conventional therapy.

The initiation of dialysis in women with chronic kidney disease during pregnancy varies by clinical practice, signaling a need for standardized care in this population, according to a study published ...

SGLT2 inhibitor use was associated with an increased risk for erythrocytosis but not thrombosis among patients with type 2 diabetes.

Serial high-sensitivity troponin I measurements may help predict death in cancer patients treated with ICIs, data suggest.